Results

48
We identified 131 patients with vertebral osteomyelitis requiring spinal instrumentation, of whom 49 94 patients had > 4 weeks follow up and were included in the primary analysis. There are no randomized, controlled trials to guide decisions about specific antimicrobial 62 regimens or duration of therapy for vertebral osteomyelitis. [1] Pathogen-directed parenteral 63
antimicrobial therapy is curative in the majority of cases.
[2-4] However, some patients have 64 complications, such as abscess formation or loss of neurological function, that require 65 significant surgical intervention. Surgical intervention involves debridement sometimes 66 accompanied by instrumentation in order to stabilize the spine.
[5] Instrumentation with 67 placement of prosthetic material such as rods, screws or plates into an infected area poses an 68 additional challenge for the infectious diseases specialist, who must determine an antimicrobial 69 treatment course. Optimal duration of antimicrobials and the need for post-treatment 70 suppressive therapy following instrumentation of vertebral osteomyelitis remains unknown. [6] 71 Approaches to treatment vary from indefinite antimicrobial therapy in an attempt to suppress a 72 presumed infection of foreign material to immediate cessation of antimicrobials after completion 73 of parenteral therapy. [6] 74
The aim of our study was to examine risk factors for treatment failure in a cohort of patients 75 requiring spinal instrumentation in the setting of acute non-contiguous vertebral osteomyelitis. 76 osteomyelitis with spinal instrumentation. Nine patients died during the hospital stay (in-hospital 150 mortality rate 6.9 per 100 patients); two of these patients died of infection-related causes. There 151 was inadequate follow up for analysis after hospital discharge on 28 patients (no follow up 152 beyond 4 weeks post operatively). Therefore, 94 patients were included in the primary outcome 153 analysis. 154
Methods
The mean age of the cohort was 55 years, 66 (70.2%) patients were male, 23 (24%) had 155 diabetes mellitus, 11 (12%) were HIV positive, and 84 (89%) had evidence of abscess on 156 imaging prior to surgery. Only seven patients (7.5%) had prior incision and drainage prior to 157 requiring spinal instrumentation and 8 (8.5%) patients had 3 or more contiguous vertebra 158 infected. Regarding spinal level of surgery and surgical approach used, 40 (42.5%) had 159 lumbar/lumbosacral surgery. Source of hematogenous seeding to the spine included 160 intravenous drug use (30 patients, 32%), intravascular access (13 patients, 13.8%), and soft 161 tissue or joint infection (13 patients, 14%). Nineteen patients had intraoperative antimicrobial 162 washout during their spinal instrumentation procedure. Duration of intravenous antimicrobials 163 was less than or equal to 6 weeks for 68 (72.4%) of patients. Twenty one patients (22.4%) were 164 prescribed oral antimicrobial suppression after completion of intravenous antimicrobials. Table  165 1 shows baseline characteristics for the group and factors that were associated with treatment 166 failure. Three factors were significantly associated with treatment failure; those who required 167 lumbar or lumbosacral surgery as opposed to surgery on other areas of the spine were more 168 likely to experience treatment failure (12/22, 55% of patients who failed vs. 18/72, 25% of 169 patients who did not fail, p=0.01), those that were HIV positive were more likely to experience 170 Table 1 ) 188
The most frequently isolated bacteria was Staphylococcus aureus (61/94, 64.9% of organisms), 
Instrumentation of a spinal area that is actively infected creates difficulty for the Infectious 238
Diseases physician who must then try to anticipate chance of infection relapse and recommend 239 appropriate antimicrobial therapy. Our study is reassuring in that it demonstrates a treatment 240 failure rate of only 23%. Although higher than previous studies, this is lower than anecdotally 241 on October 14, 2017 by guest http://aac.asm.org/ Downloaded from expected by most infectious disease physician. A recent case series described 47 cases of 242 instrumentation during spinal infection and reported a treatment failure rate of 4.3%.
[9] This was 243 followed by a review of the literature including 30 publications describing 689 cases, of which 244 only 1.7% experienced treatment failure after spinal instrumentation.
[9] Another study by 245
Carragee et al reported a 3% treatment failure rate in a cohort of immune-suppressed patients 246 requiring spinal instrumentation in the treatment of vertebral osteomyelitis.
[6] Drawing 247 conclusions from these other studies is difficult for several reasons: there is great variability 248 among the studies in terms of definition and etiology of infection (both microbiological and route 249 of infection), outcome measures differ and the majority had limited follow up. [6, 7] Additionally, 250 most studies give vague descriptions of type, route and duration of antimicrobials administered 251 and use of chronic suppression. [6, 7] Our study had a large cohort of patients, with standard case 252 and treatment failure definitions, more detail regarding etiology of infection and exclusion of 253 cases without adequate follow up. Studies which did not use a strict case definition may have 254 included non-infectious diagnoses that required placement of hardware, thus giving the 255 appearance of a smaller treatment failure rate.
[10] Our complete definition of treatment failure, 256 which included those who required a second complete course of antimicrobial therapy and long 257 follow up period likely contributed to our finding of a higher treatment failure rate. 258
259
The failure rate of 23% found in our study is similar to studies of single-stage exchange 260 prosthetic joint infection treatment strategies, which report a treatment failure rates in the order 261 of 20%.
[ Another major finding of this study is that treatment failure occurred most frequently in the early 270 post operative period, with a median time to failure of 4 months. Close follow up in the first year 271 following instrumentation by is likely to yield the greatest benefit in terms of reducing morbidity. 272
The optimal duration of parenteral antimicrobials in spinal osteomyelitis remains unknown. 273
Some small studies have reported that patients with spinal osteomyelitis experience treatment 274 failure more often when parenteral therapy was administered for less than 4 weeks. [12, 13] In 275 clinical practice, many infectious disease physicians give six weeks of parenteral antimicrobials. 276
In our study, with multivariable modeling, parenteral antimicrobials beyond 6 weeks did not 277 statistically reduce risk of failure, although power was limited and the size of effect was 278 potentially large. Even in this study, the largest cohort of this nature to date, we had limited 279 power to identify optimal duration of parenteral antimicrobial treatment. 280
We identified non-modifiable factors associated with a greater chance of treatment failure. However, in many cases suppressive antimicrobials are prescribed indefinitely to prevent 294 recurrence. [14] Given that the vast majority of infections occur in the first year after surgery 295 benefits of suppressive antimicrobials beyond 1 year appear minimal.
[15]
296
The main limitation of this study is its retrospective nature, without routine follow up for all 297 patients and standardization of antimicrobial treatments and surgeries. Given 28 patients did not 298 have follow up at 4 weeks or beyond, the true failure rate could vary from 16.8% ( 
